Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Current Opinion in Pulmonary Medicine|November 28, 2017
The asthma-obesity relationship: underlying mechanisms and treatment implicationsOrestes A Carpaij, Maarten van den BergePharmacology & Therapeutics|May 11, 2019
A review on the pathophysiology of asthma remissionOrestes A Carpaij, Janette K Burgess, Huib A M Kerstjens, et al.Respiration; International Review of Thoracic Diseases|November 8, 2023
Impact of Endobronchial Valve Treatment on Lung Function DeclineJorine E Hartman, Karin Klooster, T David Koster, et al.Respiratory Medicine|March 24, 2022
Survival in COPD patients treated with bronchoscopic lung volume reductionJorine E Hartman, Jorrit B A Welling, Karin Klooster, et al.Respiratory Medicine|September 12, 2020
Long-acting dual bronchodilator therapy (indacaterol/glycopyrronium) versus nebulized short-acting dual bronchodilator (salbutamol/ipratropium) in chronic obstructive pulmonary disease: A double-blind, randomized, placebo-controlled trialWouter H van Geffen, Orestes A Carpaij, Lotte F Westbroek, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|December 5, 2023
Lack of a transcriptional response of primary bronchial epithelial cells from patients with asthma and controls to IL-33Akshaya Keerthi Saikumar Jayalatha, Marnix R Jonker, Orestes A Carpaij, et al.ERJ Open Research|October 29, 2025
Airway wall thickness in asthma remissionLisa H van Smoorenburg, Orestes A Carpaij, Craig J Galban, et al.ERJ Open Research|October 26, 2019
Assessing small airways dysfunction in asthma, asthma remission and healthy controls using particles in exhaled airOrestes A Carpaij, Susan Muiser, Alex J Bell, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 13, 2025
Evidence for altered immune-structural cell crosstalk in cystic fibrosis revealed by single cell transcriptomicsMarijn Berg, Lisette Krabbendam, Esmee K van der Ploeg, et al.Antimicrobial Agents and Chemotherapy|October 11, 2021
Moxidectin and Ivermectin Inhibit SARS-CoV-2 Replication in Vero E6 Cells but Not in Human Primary Bronchial Epithelial CellsNilima Dinesh Kumar, Bram M Ter Ellen, Ellen M Bouma, et al.Pageof 2